VS-041
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VS-041, covering 2026-04-09 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) [Phase 1]